Patent · US Active

Nitric oxide donors for inducing neurogenesis

US8383626B2 · kind B2 · utility

0Cited by
20References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2010
Grant dateFeb 26, 2013
Priority date
Expiry dateFeb 1, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided a method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.